InteguSeal Launch in the US

Advanced Medical Solutions Grp PLC
07 February 2007


For Immediate Release                                            7 February 2007






                      Advanced Medical Solutions Group plc

                            ('AMS' or 'the Company')



        Kimberly-Clark launches InteguSeal* Microbial Sealant in the US



Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global
healthcare technology company, today announces that a novel application of its
medical adhesives technology to help reduce the risk of skin flora contamination
throughout a surgical procedure, a key factor in the development of surgical
site infections, has been launched in the US.  The product was unveiled during
the annual meeting of the Society of Thoracic Surgery in San Diego, California.



Surgical site infections occur in 2-5% of all surgical procedures and they can
lead to serious complications and increased morbidity to the patient and
significant incremental costs to health care providers.



In March 2006 AMS announced that it had entered into an exclusive agreement with
Kimberly-Clark Health Care for the marketing and distribution of InteguSeal*
Microbial Sealant in all global markets. The product consists of a film-forming
solution that bonds to the skin sealing off the spaces where bacteria can grow
and immobilises pathogens to help prevent against migration into a surgical
incision.  Easy to apply and fast-drying, InteguSeal* Microbial Sealant can be
used with a variety of patient skin preparation treatments and surgical products
such as electrocautery, sutures, staples and wound adhesives.  The versatile
film bonds to skin surfaces with different curvature, hair-content or amount or
types of flora present.



The product was launched in Europe and other geographies during 2006 and now has
been used in more than 15,000 applications during surgical procedures
internationally.  Clearance for sale in the US was granted by the FDA and
announced in October 2006 and following today's announcement, the product has
now been introduced in the world's largest market for surgical procedures.



Atlanta-based Kimberly-Clark Health Care is a business unit with revenues of
more than $1 billion, within the global Kimberly-Clark Corporation.  It
manufactures and markets a wide range of surgical products and is a leader in
several medical device categories.



Commenting on today's announcement, Dr. Don Evans, Chief Executive of AMS,
stated:



'I am delighted that InteguSeal* Microbial Sealant has been launched in the US.
With its strong  presence and focus on the operating room, Kimberly-Clark Health
Care is an ideal marketing and distribution partner for global commercialisation
of this technology.'



                                     -ENDS-



For further information, please contact:


Advanced Medical Solutions Group plc                   Tel : [phone]
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com

Buchanan Communications                                Tel: [phone]
Mark Court, Mary-Jane Johnson





Notes to Editors:



Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $13 billion global woundcare market.



Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.



In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.



The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives that offer benefits over sutures and
staples for closing wounds sold direct to hospitals or through distributors.



AMS's technology and products currently serve the majority of the key global
markets and strategic partners.





Kimberly-Clark in the Healthcare Environment



Around the world, medical professionals turn to Kimberly-Clark for a wide
portfolio of solutions that improve the health, hygiene and well-being of their
patients and staff.  As part of their healing mission, caregivers rely on
Kimberly-Clark to deliver clinical solutions and educational resources that they
can depend on to prevent, diagnose and manage a wide variety of
healthcare-associated infections.  This over $1 billion global enterprise of
Kimberly-Clark Corporation holds the No. 1 and No. 2 market share positions in
several categories including infection control solutions, surgical solutions,
pain management and digestive health. And throughout the care continuum,
patients and staff alike trust Kimberly-Clark* medical supplies and devices,
KLEENEX(R) tissues, Kimberly-Clark* professional skin care products, and SCOTT
(R) towels for day-to-day needs. For more information, please visit http://
www.kchealthcare.com.



(R)Registered Trademark or * Trademark of Kimberly-Clark Worldwide, Inc. (c)
2007 KCWW.




                      This information is provided by RNS
            The company news service from the London Stock Exchange